Skip to main content

Cyrus Biotechnology makes acquisition after raising $18M

Cyrus, founded in 2014, offers software to help with protein design and modeling. Its technology is aimed at helping clients bring new drugs to market.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.